Dagmara Borucka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dagmara Borucka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Mleczak
Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307 Dresden, Germany
1 shared publication - Jenifer Cameron
Beatson Institute for Cancer Research, Garscube Estate, Switchback Road Glasgow G61 1BD, UK
1 shared publication - June Munro
Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK
1 shared publication - Mads Gabrielsen
Neil Bulleid Integrated Protein Analysis Facility, MVLS Shared Research Facilities, University of Glasgow, Glasgow, UK
1 shared publication - Maike Schuldt
Beatson Institute for Cancer Research, Garscube Estate, Switchback Road Glasgow G61 1BD, UK
1 shared publication - Mark Baugh
Beatson Institute for Cancer Research, Garscube Estate, Switchback Road Glasgow G61 1BD, UK
1 shared publication
Latest Publications
- Open Access
- 14 August 2013
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 11 (1) , 58
Cucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary target
Background: Cucurbitacins are a class of triterpenoid natural compounds with potent bioactivities that led to their use as traditional remedies, and which continue to attract considerable attention as chemical biology tools and potential therapeutics. One obvious target is the actin-cytoskeleton; treatment with cucurbitacins results in cytoskeletal rearrangements that impact upon motility and cell morphology. Findings: Cucurbitacin reacted with protein cysteine thiols as well as dithiothreitol, and we propose that the cucurbitacin mechanism of action is through broad protein thiol modifications that could result in inhibition of numerous protein targets. An example of such a target protein is Cofilin1, whose filamentous actin severing activity is inhibited by cucurbitacin conjugation. Conclusions: The implications of these results are that cucurbitacins are unlikely to be improved for selectivity by medicinal chemistry and that their use as chemical biology probes to analyse the role of specific signalling pathways should be undertaken with caution.
- 14 August 2013
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 11 (1) , 58
Open AccessCucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary target
Background: Cucurbitacins are a class of triterpenoid natural compounds with potent bioactivities that led to their use as traditional remedies, and which continue to attract considerable attention as chemical biology tools and potential therapeutics. One obvious target is the actin-cytoskeleton; treatment with cucurbitacins results in cytoskeletal rearrangements that impact upon motility and cell morphology. Findings: Cucurbitacin reacted with protein cysteine thiols as well as dithiothreitol, and we propose that the cucurbitacin mechanism of action is through broad protein thiol modifications that could result in inhibition of numerous protein targets. An example of such a target protein is Cofilin1, whose filamentous actin severing activity is inhibited by cucurbitacin conjugation. Conclusions: The implications of these results are that cucurbitacins are unlikely to be improved for selectivity by medicinal chemistry and that their use as chemical biology probes to analyse the role of specific signalling pathways should be undertaken with caution.